A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/15/2011	US20110306607 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/15/2011	US20110306606 Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same
12/15/2011	US20110306605 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
12/15/2011	US20110306604 3- and 6-quinolines with n-attached heterocyclic cgrp receptor antagonists
12/15/2011	US20110306603 Large substituent, non-phenolic opioids and methods of use thereof
12/15/2011	US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011	US20110306601 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression
12/15/2011	US20110306600 Novel therapeutic compounds
12/15/2011	US20110306599 Indole compounds and pharmaceutical use thereof
12/15/2011	US20110306598 Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure
12/15/2011	US20110306597 Nicotinamide Derivatives
12/15/2011	US20110306596 Benzazepine inhibitors of gamma-secretase
12/15/2011	US20110306595 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/15/2011	US20110306594 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
12/15/2011	US20110306593 Gamma secretase modulators
12/15/2011	US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	US20110306591 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
12/15/2011	US20110306590 Aryl- and heteroaryl- nitrogen-heterocyclic compounds as pde10 inhibitors
12/15/2011	US20110306589 Nitrogen containing heteroaryl compounds
12/15/2011	US20110306588 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
12/15/2011	US20110306587 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
12/15/2011	US20110306586 NMDA Receptor Modulators and Uses Thereof
12/15/2011	US20110306585 Metal Complexes of N-Heterocyclic Carbenes
12/15/2011	US20110306584 Porphyrin Catalysts and Methods of Use Thereof
12/15/2011	US20110306583 Testosterone Gel And Method Of Use
12/15/2011	US20110306582 Androgen pharmaceutical composition and method for treating depression
12/15/2011	US20110306581 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
12/15/2011	US20110306580 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
12/15/2011	US20110306579 Methods of neuroprotection using neuroprotective steroids and a vitamin d
12/15/2011	US20110306578 Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
12/15/2011	US20110306577 Topical skin cream comprising phosphatidylcholine dha and l-tyrosine
12/15/2011	US20110306576 Compounds and methods relating thereto
12/15/2011	US20110306575 Medical and nutritional applications of highly refined cellulose
12/15/2011	US20110306574 Inhibitors of f18+ e coli binding
12/15/2011	US20110306573 Nucleoside derivatives as inhibitors of viral polymerases
12/15/2011	US20110306572 COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL InHIBITORS OF EGFR [ErbB1] AND HER-2 [ErbB2]
12/15/2011	US20110306571 Methods for treating cancer
12/15/2011	US20110306570 Na/K-Atpase Expression as an Indicator for the Treatment of Cancer
12/15/2011	US20110306567 Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain
12/15/2011	US20110306566 Topical skin treatment kits
12/15/2011	US20110306564 Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these
12/15/2011	US20110306560 Boronic ester and acid compounds, synthesis and uses
12/15/2011	US20110306559 Methods and compositions for treating neuropathic pain
12/15/2011	US20110306556 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
12/15/2011	US20110306552 Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2
12/15/2011	US20110306547 Lhrh - antagonists in the treatment of fertility disorders
12/15/2011	US20110306542 Novel glp-1 receptor stabilizers and modulators
12/15/2011	US20110306541 Methods for treating hcv
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110306493 Sulfoximinamide Compounds for Combating Animal Pests
12/15/2011	US20110306018 Methods For Improving Pregnancy Outcomes
12/15/2011	US20110305784 Fractionated products obtained from gamboge resin, and medical uses of the same
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305778 Chemically Stabilized Anti-Dandruff Compositions For Use In Personal Care Compositions
12/15/2011	US20110305776 Thiochromene derivatives as hif hydroxylase inhibitors
12/15/2011	US20110305774 Treatment of retroviral reservoirs exploiting oxidative stress
12/15/2011	US20110305771 Krill Extracts for Treatment of Cardiovascular Diseases
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305769 Branched cationic lipids for nucleic acids delivery system
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305765 Preparation and methodology of silk fibroin nanoparticles
12/15/2011	US20110305764 Use of a Mare's Milk Concentrate Dried on a Highly-Dispersed, Biologically Inert Matrix
12/15/2011	US20110305762 Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
12/15/2011	US20110305760 Tissue regeneration system
12/15/2011	US20110305758 Orally disintegrating tablet having inner core
12/15/2011	US20110305757 New pharmaceutical combinations
12/15/2011	US20110305756 Coated solid preparation
12/15/2011	US20110305754 Controlled release micro-capsule for osteogenic action
12/15/2011	US20110305751 Glutathione-based drug delivery system
12/15/2011	US20110305747 Combination of dapsone with other anti-acne agents
12/15/2011	US20110305744 Preparation for vaginal and rectal use and relative production method
12/15/2011	US20110305743 Ocular implant made by a double extrusion process
12/15/2011	US20110305734 Nucleic acid nanoparticles and uses therefor
12/15/2011	US20110305733 Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
12/15/2011	US20110305732 Methods and uses for inhibiting platelet coagulation
12/15/2011	US20110305731 Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarries
12/15/2011	US20110305729 Scriptaid Isosteres and Their Use in Therapy
12/15/2011	US20110305724 Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
12/15/2011	US20110305719 Inhibition of Pro-Inflammatory Cytokine Induced Response
12/15/2011	US20110305717 Cultured myeloid dendritic cells isolated from peyer's patches and uses thereof
12/15/2011	US20110305713 Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
12/15/2011	US20110305710 Novel compounds for the treatment of glaucoma or ocular hypertension
12/15/2011	US20110305709 Calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathological thrombus formation
12/15/2011	US20110305707 Compositions and methods for treating cancer
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305689 Treatment of chronic inflammatory respiratory disorders
12/15/2011	US20110305685 Supramolecular approach for preparation of size controllable nanoparticles
12/15/2011	US20110305676 Methods for enhancing hematopoietic stem/progenitor cell engraftment
12/15/2011	US20110305675 Methods for expansion of hematopoietic stem and progenitor cells
12/15/2011	US20110305670 Nucleic acid encoding fusion polypeptides that prevent or inhibit hiv infection
12/15/2011	US20110305666 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
12/15/2011	US20110305661 Carbazole Compounds and Therapeutic Uses of the Compounds
12/15/2011	US20110305660 Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization
12/15/2011	US20110305647 Use of a polysaccharide which is excreted by the vibrio diabolicus species for the regeneration and protection of the periodontium
12/15/2011	US20110305646 Fatty acid monoglyceride compositions
12/15/2011	US20110305645 Crystal form of glycopyrronium chloride
12/15/2011	US20110305640 Method to treat psoriasis and other hyperproliferative skin disorders
12/15/2011	US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011	US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/15/2011	US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer

1 ... 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 ... 7860